Follow The Filings

GKOS Glaukos Corporation

Health Care, filed as GLAUKOS CORP (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q3

  • 2 Owners
  • Max 2.9%
  • $91M
  • 2 add

In 2026 Q3 Ben Jacobs and Polen Capital Management added to Glaukos.

Who owns this now

Largest portfolio weights among holders, up to 2.9% (Ben Jacobs, Anomaly Capital Management). Not free-float ownership.

  1. Ben Jacobs Add 2.9%
  2. Polen Capital Management Add 0.06%

Who owns GKOS

Sorted by value, long equity only, as of 2026 Q3.

History
Ben Jacobs, Anomaly Capital Management 2.9%, was 1.5% Add +88.2% 519,310 $85M History
Polen Capital Management 0.06%, was <0.01% Add +562.2% 31,907 $5.2M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by GKOS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GKOS insider trades
  • None no insider bought on the open market
  • $31.8M sold by 5 insiders outside a trading plan
  • $104M sold by 5 insiders under 10b5-1 plans
  1. Thomas William Burns CEO
    Planned sale
    $42.6M 180,000 shares at $236.89 74% of stake
    Traded Nov 18 Filed Nov 20
  2. Alex R. Thurman CFO
    Planned sale
    $3.6M 15,000 shares at $236.92 26% of stake
    Traded Nov 18 Filed Nov 20
  3. Joseph E. Gilliam COO
    Planned sale
    $215K 861 shares at $250.00 1.2% of stake
    Traded Nov 16 Filed Nov 18
  4. Joseph E. Gilliam COO
    Planned sale
    $11.1M 44,917 shares at $246.32 39% of stake
    Traded Nov 12 Filed Nov 16
  5. Gilbert H. Kliman Director
    Sale
    $633K 2,500 shares at $253.00 6.3% of stake
    Traded Nov 4 Filed Nov 5
  6. Tomas Navratil Chief Development Officer
    Sale
    $10.6M 44,436 shares at $238.97 54% of stake
    Traded Oct 30 Filed Nov 3
  7. Tomas Navratil Chief Development Officer
    Planned sale
    $251K 1,527 shares at $164.45 2.2% of stake
    Traded Oct 5 Filed Oct 7
  8. Tomas Navratil Chief Development Officer
    Planned sale
    $249K 1,615 shares at $154.28 2.2% of stake
    Traded Sep 25 Filed Sep 28
  9. Tomas Navratil Chief Development Officer
    Planned sale
    $243K 1,457 shares at $166.92 2% of stake
    Traded Sep 16 Filed Sep 18
  10. Tomas Navratil Chief Development Officer
    Sale
    $2.5M 13,744 shares at $180.67 16% of stake
    Traded Aug 28 Filed Sep 1
  11. Gilbert H. Kliman Director
    Sale
    $475K 2,500 shares at $190.00 6.3% of stake
    Traded Aug 19 Filed Aug 20
  12. Joseph E. Gilliam COO
    Sale
    $10.8M 60,000 shares at $179.74 45% of stake
    Traded Aug 11 Filed Aug 13
  13. Alex R. Thurman CFO
    Planned sale
    $3.6M 20,000 shares at $180.13 31% of stake
    Traded Aug 7 Filed Aug 11
  14. Leana Wen Director
    Sale
    $88K 525 shares at $167.63 2.4% of stake
    Traded Jul 31 Filed Aug 3
  15. Alex R. Thurman CFO
    Planned sale
    $1.6M 10,000 shares at $160.00 19% of stake
    Traded Jul 16 Filed Jul 21

Also filed in the last 12 months, not counted as buying or selling: 36 option exercises, 32 share withholdings for taxes, 25 stock grants, and 8 gifts.

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 7.01,9.01
10-Q
8-K 2.02,7.01,9.01
8-K 7.01,9.01
8-K 2.02,7.01,9.01
10-Q

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $314.71M $383.48M $507.44M
Gross profit $239.14M $289.45M $282.76M
Gross margin * 76.0% 75.5% 55.7%
Net income -$134.66M -$146.37M -$187.69M
Net margin * -42.8% -38.2% -37.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $395.46M $449.79M $474.98M
Total non-current assets * $544.95M $524.96M $418.5M
Total assets $940.41M $974.76M $893.49M
Total current liabilities $74.01M $75.12M $101.28M
Total non-current liabilities * $404.63M $132.7M $136.06M
Total equity $461.77M $766.93M $656.16M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$57.76M -$61.32M -$14.79M
Cash from investing $14.1M $47.83M -$77.61M
Cash from financing $15.04M $91.54M $11.89M
Net change in cash -$27.28M $75.04M -$79.71M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf